In silico analyses suggest that DNAJC25 mRNA expression is also reduced in breast cancer tissues, and high DNAJC25 mRNA expression is correlated with favorable post-progression survival in breast cancer [205]. This evidence concerns the gene DNAJC25 and breast cancer.